These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8046387)

  • 1. Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9.
    Burroughs JN; O'Hara RS; Smale CJ; Hamblin C; Walton A; Armstrong R; Mertens PP
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1849-57. PubMed ID: 8046387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4.
    Mertens PP; Burroughs JN; Anderson J
    Virology; 1987 Apr; 157(2):375-86. PubMed ID: 3029978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.
    Maree S; Durbach S; Huismans H
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():333-7. PubMed ID: 9472617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
    Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
    Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced infectivity of modified bluetongue virus particles for two insect cell lines and for two Culicoides vector species.
    Mertens PP; Burroughs JN; Walton A; Wellby MP; Fu H; O'Hara RS; Brookes SM; Mellor PS
    Virology; 1996 Mar; 217(2):582-93. PubMed ID: 8610450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African horse sickness virus structure.
    Roy P; Mertens PP; Casal I
    Comp Immunol Microbiol Infect Dis; 1994; 17(3-4):243-73. PubMed ID: 8001348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of African horsesickness virus serotype 4-induced polypeptides in Vero cells and their reactivity in Western immunoblotting.
    Laviada MD; Arias M; Sánchez-Vizcaíno JM
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():81-7. PubMed ID: 8423451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baculovirus expression of non-structural protein NS2 and core protein VP7 of African horsesickness virus serotype 3 and their use as antigens in an indirect ELISA.
    Bremer CW; du Plessis DH; van Dijk AA
    J Virol Methods; 1994 Jul; 48(2-3):245-56. PubMed ID: 7989441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complete sequence of the group-specific antigen, VP7, of African horsesickness disease virus serotype 4 reveals a close relationship to bluetongue virus.
    Roy P; Hirasawa T; Fernandez M; Blinov VM; Sanchez-Vixcain Rodrique JM
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1237-41. PubMed ID: 1646273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insight into African horsesickness virus infection.
    Manole V; Laurinmäki P; Van Wyngaardt W; Potgieter CA; Wright IM; Venter GJ; van Dijk AA; Sewell BT; Butcher SJ
    J Virol; 2012 Aug; 86(15):7858-66. PubMed ID: 22593166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.
    Chuma T; Le Blois H; Sánchez-Vizcaíno JM; Diaz-Laviada M; Roy P
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():925-31. PubMed ID: 1378881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and properties of monoclonal antibodies against African horsesickness virus, serotype 3.
    Van Wyngaardt W; Du Plessis DH; Van Wyngaardt S; Verschoor JA
    Onderstepoort J Vet Res; 1992 Jun; 59(2):129-33. PubMed ID: 1513593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
    Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of empty african horse sickness virus particles.
    Maree S; Maree FF; Putterill JF; de Beer TAP; Huismans H; Theron J
    Virus Res; 2016 Feb; 213():184-194. PubMed ID: 26686484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus.
    Oldfield S; Adachi A; Urakawa T; Hirasawa T; Roy P
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2649-56. PubMed ID: 2174958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of competitive ELISA for serodiagnosis on African horsesickness virus using baculovirus expressed VP7 and monoclonal antibody.
    Kweon CH; Kwon BJ; Ko YJ; Kenichi S
    J Virol Methods; 2003 Oct; 113(1):13-8. PubMed ID: 14500122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.